The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Saved in:
| Title: | The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. |
|---|---|
| Authors: | Chaccour C; Instituto de Salud Global de Barcelona, Barcelona, Spain. carlos.chaccour@isglobal.org., Ruiz-Castillo P; Instituto de Salud Global de Barcelona, Barcelona, Spain., Richardson MA; Instituto de Salud Global de Barcelona, Barcelona, Spain., Moncunill G; Instituto de Salud Global de Barcelona, Barcelona, Spain., Casellas A; Instituto de Salud Global de Barcelona, Barcelona, Spain., Carmona-Torre F; Instituto de Salud Global de Barcelona, Barcelona, Spain., Giráldez M; Instituto de Salud Global de Barcelona, Barcelona, Spain., Mota JS; Instituto de Salud Global de Barcelona, Barcelona, Spain., Yuste JR; Instituto de Salud Global de Barcelona, Barcelona, Spain., Azanza JR; Instituto de Salud Global de Barcelona, Barcelona, Spain., Fernández M; Instituto de Salud Global de Barcelona, Barcelona, Spain., Reina G; Instituto de Salud Global de Barcelona, Barcelona, Spain., Dobaño C; Instituto de Salud Global de Barcelona, Barcelona, Spain., Brew J; Instituto de Salud Global de Barcelona, Barcelona, Spain., Sadaba B; Instituto de Salud Global de Barcelona, Barcelona, Spain., Hammann F; Instituto de Salud Global de Barcelona, Barcelona, Spain., Rabinovich R; Instituto de Salud Global de Barcelona, Barcelona, Spain. |
| Source: | Trials [Trials] 2020 Jun 08; Vol. 21 (1), pp. 498. Date of Electronic Publication: 2020 Jun 08. |
| Publication Type: | Clinical Trial Protocol; Letter |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-020-04421-z |
